Tu1067: STRINGENT SCREENING STRATEGY LEADS TO SIGNIFICANT REDUCTION OF TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING ANTI-TNF THERAPY: A REAL-WORLD COHORT ANALYSIS FROM A TUBERCULOSIS ENDEMIC REGION.

MLA

Kumar, Peeyush, et al. “Tu1067: STRINGENT SCREENING STRATEGY LEADS TO SIGNIFICANT REDUCTION OF TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING ANTI-TNF THERAPY: A REAL-WORLD COHORT ANALYSIS FROM A TUBERCULOSIS ENDEMIC REGION.” Gastroenterology (00165085), vol. 162, no. 7, May 2022, p. S-870. EBSCOhost, https://doi.org/10.1016/S0016-5085(22)62056-0.

APA

Kumar, P., Vuyyuru, S. K., Kumar, B., Sahu, P., Goyal, S., Madhu, D., Jain, S., Ranjan, M. K., Mundhra, S., Golla, R., Singh, M. K., Virmani, S., Sharma, R., Makharia, G. K., Kedia, S., & Ahuja, V. (2022). Tu1067: STRINGENT SCREENING STRATEGY LEADS TO SIGNIFICANT REDUCTION OF TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING ANTI-TNF THERAPY: A REAL-WORLD COHORT ANALYSIS FROM A TUBERCULOSIS ENDEMIC REGION. Gastroenterology (00165085), 162(7), S-870. https://doi.org/10.1016/S0016-5085(22)62056-0

Chicago

Kumar, Peeyush, Sudheer K. Vuyyuru, Bhaskar Kumar, Pabitra Sahu, Sandeep Goyal, Deepak Madhu, Saransh Jain, et al. 2022. “Tu1067: STRINGENT SCREENING STRATEGY LEADS TO SIGNIFICANT REDUCTION OF TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING ANTI-TNF THERAPY: A REAL-WORLD COHORT ANALYSIS FROM A TUBERCULOSIS ENDEMIC REGION.” Gastroenterology (00165085) 162 (7): S-870. doi:10.1016/S0016-5085(22)62056-0.